Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 5
Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Basic tumor immunology
Original research
Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation
Online download statistics by month:
Online download statistics by month: May 2022 to February 2024
Abstract
Full
Pdf
May 2022
582
585
363
Jun 2022
455
463
188
Jul 2022
251
256
72
Aug 2022
217
219
66
Sep 2022
217
223
88
Oct 2022
212
215
82
Nov 2022
187
190
84
Dec 2022
150
151
55
Jan 2023
131
131
44
Feb 2023
158
160
93
Mar 2023
180
180
60
Apr 2023
158
162
54
May 2023
143
145
46
Jun 2023
141
142
50
Jul 2023
127
127
53
Aug 2023
152
152
66
Sep 2023
147
148
52
Oct 2023
175
176
79
Nov 2023
167
167
56
Dec 2023
163
164
60
Jan 2024
112
112
68
Feb 2024
108
108
41
Total
4333
4376
1820
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?